Protein kinase C regulates bombesin-induced rapid VEGF secretion in neuroblastoma cells

Cameron Schlegel1, Pritha Paul, Sora Lee

  • 1Department of Pediatric Surgery, 2200 Children's Way, DOT 7100, Vanderbilt University Medical Center, Nashville, TN 37232, USA.

Anticancer Research
|November 17, 2012
PubMed
Abstract

Insights

Protein kinase C (PKC) drives rapid vascular endothelial growth factor (VEGF) secretion via gastrin-releasing peptide (GRP) receptor signaling in neuroblastoma cells, impacting tumor growth.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Gastrin-releasing peptide (GRP) receptor signaling in neovascularization remains unclear.
  • Investigating the cellular mechanisms of GRP receptor regulation of vascular endothelial growth factor (VEGF) in neuroblastoma.

Purpose of the Study:

  • To elucidate the intracellular signaling pathways mediating GRP receptor-induced VEGF release.
  • To determine the role of protein kinase C (PKC) in this process.

Main Methods:

  • BE(2)-C neuroblastoma cells were treated with bombesin (BBS), a PKC agonist (PMA), or a PKC inhibitor (GFX).
  • VEGF secretion, and phosphorylation of AKT, ERK, and PKD were analyzed.
  • Immunofluorescent staining for VEGF was performed.

Main Results:

  • Bombesin (BBS) significantly increased VEGF secretion within 30 minutes.
  • PMA treatment alone elevated VEGF secretion, synergistically enhanced by GRP.
  • GFX inhibited PMA-stimulated VEGF secretion, indicating PKC's role.

Conclusions:

  • Protein kinase C (PKC) is essential for rapid VEGF secretion mediated by GRP receptor signaling in neuroblastoma.
  • VEGF inhibition markedly reduced GRP-induced cell proliferation, highlighting its importance in neuroblastoma tumorigenesis.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...